Literature DB >> 24349936

Correlation between Serum Levels of Protein-Bound Uremic Toxins in Hemodialysis Patients Measured by LC/MS/MS.

Yoshiharu Itoh1, Atsuko Ezawa1, Kaori Kikuchi1, Yoshinari Tsuruta2, Toshimitsu Niwa3.   

Abstract

Uremic toxins are involved in a variety of symptoms in advanced chronic kidney disease. Especially, the accumulation of protein-bound uremic toxins in the blood of dialysis patients might play an important role in the development of cardiovascular disease. Serum concentration of protein-bound uremic toxins such as indoxyl sulfate, indoxyl glucuronide, indoleacetic acid, p-cresyl sulfate, p-cresyl glucuronide, phenyl sulfate, phenyl glucuronide, phenylacetic acid, phenylacetylglutamine, hippuric acid, 4-ethylphenyl sulfate, and 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid (CMPF) in hemodialysis patients were simultaneously measured by liquid chromatography/tandem mass spectrometry. Serum levels of these protein-bound uremic toxins were increased in hemodialysis patients. Indoxyl sulfate, p-cresyl sulfate, and CMPF could not be removed efficiently by hemodialysis due to their high protein-binding ratios. Serum level of total indoxyl sulfate did not show any significant correlation with total p-cresyl sulfate. However, free indoxyl sulfate correlated with free p-cresyl sulfate, and reduction rate by hemodialysis of indoxyl sulfate correlated with that of p-cresyl sulfate. Serum levels of total and free indoxyl sulfate showed significantly positive correlation with those of indoxyl glucuronide, phenyl sulfate, and phenyl glucuronide. Serum levels of total and free p-cresyl sulfate showed significantly positive correlation with those of p-cresyl glucuronide, phenylacetylglutamine, and phenylacetic acid. Indoxyl sulfate and indoxyl glucuronide are produced from indole which is produced in the intestine from tryptophan by intestinal bacteria. p-Cresyl sulfate and p-cresyl glucuronide are produced from p-cresol which is produced in the intestine from tyrosine by intestinal bacteria. Thus, intestinal bacteria play an important role in the metabolism of protein-bound uremic toxins.

Entities:  

Keywords:  indoxyl glucuronide; indoxyl sulfate; p-cresyl glucuronide; p-cresyl sulfate; phenyl sulfate; phenylacetylglutamine

Year:  2013        PMID: 24349936      PMCID: PMC3810223          DOI: 10.5702/massspectrometry.S0017

Source DB:  PubMed          Journal:  Mass Spectrom (Tokyo)        ISSN: 2186-5116


  24 in total

Review 1.  Review on uremic toxins: classification, concentration, and interindividual variability.

Authors:  Raymond Vanholder; Rita De Smet; Griet Glorieux; Angel Argilés; Ulrich Baurmeister; Philippe Brunet; William Clark; Gerald Cohen; Peter Paul De Deyn; Reinhold Deppisch; Beatrice Descamps-Latscha; Thomas Henle; Achim Jörres; Horst Dieter Lemke; Ziad A Massy; Jutta Passlick-Deetjen; Mariano Rodriguez; Bernd Stegmayr; Peter Stenvinkel; Ciro Tetta; Christoph Wanner; Walter Zidek
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

Review 2.  Recent progress in the analysis of uremic toxins by mass spectrometry.

Authors:  Toshimitsu Niwa
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-11-27       Impact factor: 3.205

Review 3.  Mass spectrometry in the search for uremic toxins.

Authors:  T Niwa
Journal:  Mass Spectrom Rev       Date:  1997 Nov-Dec       Impact factor: 10.946

4.  Reduction in protein-bound solutes unacceptable as marker of dialysis efficacy during alternate-night nocturnal hemodialysis.

Authors:  Bjorn Meijers; Nigel D Toussaint; Timothy Meyer; Bert Bammens; Kristin Verbeke; Yves Vanrenterghem; Peter G Kerr; Pieter Evenepoel
Journal:  Am J Nephrol       Date:  2011-07-23       Impact factor: 3.754

5.  Colonic contribution to uremic solutes.

Authors:  Pavel A Aronov; Frank J-G Luo; Natalie S Plummer; Zhe Quan; Susan Holmes; Thomas H Hostetter; Timothy W Meyer
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

6.  Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production.

Authors:  Yoshiharu Itoh; Atsuko Ezawa; Kaori Kikuchi; Yoshinari Tsuruta; Toshimitsu Niwa
Journal:  Anal Bioanal Chem       Date:  2012-03-25       Impact factor: 4.142

7.  The determination of urinary phenylacetylglutamine as phenylacetic acid. Studies on its origin in normal subjects and children with cystic fibrosis.

Authors:  J W Seakins
Journal:  Clin Chim Acta       Date:  1971-11       Impact factor: 3.786

Review 8.  Update of uremic toxin research by mass spectrometry.

Authors:  Toshimitsu Niwa
Journal:  Mass Spectrom Rev       Date:  2011-02-16       Impact factor: 10.946

9.  Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis.

Authors:  T Niwa; M Ise
Journal:  J Lab Clin Med       Date:  1994-07

10.  Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate.

Authors:  T Niwa; M Ise; T Miyazaki
Journal:  Am J Nephrol       Date:  1994       Impact factor: 3.754

View more
  12 in total

1.  Restoring glucose uptake rescues neutrophil dysfunction and protects against systemic fungal infection in mouse models of kidney disease.

Authors:  Chetan V Jawale; Kritika Ramani; De-Dong Li; Bianca M Coleman; Rohan S Oberoi; Saran Kupul; Li Lin; Jigar V Desai; Greg M Delgoffe; Michail S Lionakis; Filitsa H Bender; Alexander J Prokopienko; Thomas D Nolin; Sarah L Gaffen; Partha S Biswas
Journal:  Sci Transl Med       Date:  2020-06-17       Impact factor: 17.956

2.  Impact of a 7-day homogeneous diet on interpersonal variation in human gut microbiomes and metabolomes.

Authors:  Leah Guthrie; Sean Paul Spencer; Dalia Perelman; Will Van Treuren; Shuo Han; Feiqiao Brian Yu; Erica D Sonnenburg; Michael A Fischbach; Timothy W Meyer; Justin L Sonnenburg
Journal:  Cell Host Microbe       Date:  2022-05-27       Impact factor: 31.316

3.  Uremia Coupled with Mucosal Damage Predisposes Mice with Kidney Disease to Systemic Infection by Commensal Candida albicans.

Authors:  Chetan V Jawale; De-Dong Li; Kritika Ramani; Li Lin; Kelvin Li; Barbara Methe; Partha Sarathi Biswas
Journal:  Immunohorizons       Date:  2021-01-15

Review 4.  Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions.

Authors:  Linda S Zhang; Sean S Davies
Journal:  Genome Med       Date:  2016-04-21       Impact factor: 11.117

5.  Postoperative changes in the retinal thickness and volume after vitrectomy for epiretinal membrane and internal limiting membrane peeling.

Authors:  Jae Yon Won; Mirinae Kim; Young-Hoon Park
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

6.  Efficacy of Divinylbenzenic Resin in Removing Indoxyl Sulfate and P-Cresol Sulfate in Hemodialysis Patients: Results From an In Vitro Study and An In Vivo Pilot Trial (xuanro4-Nature 3.2).

Authors:  Maria Teresa Rocchetti; Carmela Cosola; Ighli di Bari; Stefania Magnani; Vanessa Galleggiante; Letizia Scandiffio; Giuseppe Dalfino; Giuseppe Stefano Netti; Mauro Atti; Roberto Corciulo; Loreto Gesualdo
Journal:  Toxins (Basel)       Date:  2020-03-10       Impact factor: 4.546

Review 7.  Circulating Metabolites Originating from Gut Microbiota Control Endothelial Cell Function.

Authors:  Amedeo Amedei; Lucia Morbidelli
Journal:  Molecules       Date:  2019-11-05       Impact factor: 4.411

8.  Serum total indoxyl sulfate and clinical outcomes in hemodialysis patients: results from the Japan Dialysis Outcomes and Practice Patterns Study.

Authors:  Suguru Yamamoto; Douglas S Fuller; Hirotaka Komaba; Takanobu Nomura; Ziad A Massy; Brian Bieber; Bruce Robinson; Ronald Pisoni; Masafumi Fukagawa
Journal:  Clin Kidney J       Date:  2020-07-31

9.  Is Fluorescence Valid to Monitor Removal of Protein Bound Uremic Solutes in Dialysis?

Authors:  Jürgen Arund; Merike Luman; Fredrik Uhlin; Risto Tanner; Ivo Fridolin
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

Review 10.  Gut microbiota derived metabolites in cardiovascular health and disease.

Authors:  Zeneng Wang; Yongzhong Zhao
Journal:  Protein Cell       Date:  2018-05-03       Impact factor: 14.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.